FIBBI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 6.188
EU - Europa 4.912
AS - Asia 1.009
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
OC - Oceania 2
Totale 12.134
Nazione #
US - Stati Uniti d'America 6.169
PL - Polonia 1.567
RU - Federazione Russa 799
SE - Svezia 643
IE - Irlanda 574
IT - Italia 500
HK - Hong Kong 334
UA - Ucraina 250
SG - Singapore 229
CN - Cina 188
DE - Germania 179
GB - Regno Unito 130
FI - Finlandia 121
JO - Giordania 115
IN - India 83
VN - Vietnam 39
CH - Svizzera 35
BE - Belgio 32
AT - Austria 26
FR - Francia 23
CA - Canada 18
TR - Turchia 16
SC - Seychelles 11
NL - Olanda 9
ES - Italia 6
EU - Europa 6
LV - Lettonia 5
NO - Norvegia 4
RO - Romania 4
GR - Grecia 3
KR - Corea 3
TN - Tunisia 2
AU - Australia 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
JP - Giappone 1
MD - Moldavia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 12.134
Città #
Warsaw 1.566
Fairfield 864
Chandler 744
Dublin 573
Ashburn 460
Jacksonville 434
Woodbridge 424
Seattle 382
Cambridge 324
Houston 305
Wilmington 285
Ann Arbor 267
Hong Kong 216
Singapore 176
Princeton 156
Florence 138
Altamura 111
Lawrence 111
Buffalo 107
Boardman 95
Boston 89
Medford 75
Shanghai 69
Mumbai 66
San Diego 52
Beijing 46
New York 34
Moscow 33
Brussels 32
Dong Ket 31
Bern 30
Vienna 26
Norwalk 25
Santa Clara 24
West Jordan 22
Falls Church 17
Kent 17
Milan 17
Hillsboro 16
Izmir 15
Los Angeles 15
Pune 14
Salerno 14
Toronto 14
Frankfurt Am Main 12
Andover 11
Phoenix 9
Verona 9
Auburn Hills 8
Helsinki 8
London 8
Bremen 7
Redmond 7
Zhengzhou 7
Barcelona 6
Rome 6
Bari 5
Catania 5
Fiesole 5
Laurel 5
Riga 5
Tappahannock 5
Bologna 4
Grafing 4
Hangzhou 4
Oslo 4
Padova 4
Salt Lake City 4
San Mateo 4
Shenzhen 4
Cecina 3
Chiusi 3
Hounslow 3
Naaldwijk 3
Old Bridge 3
Palaiseau 3
Poggio a Caiano 3
Prato 3
Timisoara 3
Amsterdam 2
Bientina 2
Birmingham 2
Casagiove 2
Castel Ritaldi 2
Chiswick 2
Formigine 2
Frankfurt am Main 2
Groningen 2
Hanover 2
Kilburn 2
Leawood 2
Nanjing 2
Napoli 2
Pian di Scò 2
Pisa 2
Prescot 2
Redwood City 2
San Giorgio A Cremano 2
Santa Monica 2
Scandicci 2
Totale 8.760
Nome #
Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis 264
Chronic resveratrol treatment inhibits MRC5 fibroblast SASP-related pro-tumoral effects on melanoma cells 259
GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides 256
The acidic microenvironment as a possible niche of dormant tumor cells 248
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells 237
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression 231
Type II CRISPR/Cas9 approach in the oncological therapy 210
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. 197
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 191
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. 189
Oleuropein aglycone attenuates the pro-angiogenic phenotype of senescent fibroblasts: a functional study in endothelial cells 175
Correction: Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: Deregulation in Systemic sclerosis (PLoS ONE (2013) 8, 7, (e68117) doi: 10.1371/journal.pone.0068117) 162
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme 147
Anoikis resistance as a further trait of acidic-adapted melanoma cells 140
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma 137
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 132
Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis. 129
Endothelial Progenitor Cells as Shuttle of Anticancer Agents 128
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: The amoeboid angiogenesis 127
Urokinase and its receptor in follicular and inflammatory cysts of the jaws. 125
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 121
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases. 118
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. 116
Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system. 113
Sulphated polysaccharides and the differentiation of the cellular slime mould Dictyostelium discoideum 109
Intercellular glycosaminoglycans in human cancer 108
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent Associated Secretory Phenotype" (SASP) on endothelial colony forming cells: the role of IL8 107
Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. 106
Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor. 106
Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH 105
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. 104
Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way. 103
GLYCOSAMINOGLYCANS AND EUKARIOTIC CELL CONTROL. 101
CELL SURFACE GLYCOSAMINOGLYCANS IN NORMAL END LEUKEMIC LEUKOCYTES. 101
Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. 96
Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients. 96
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 95
The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. 95
ELECTROPHORETIC CHARACTERIZATION OF SURFACE HEPARAN SULPHATES IN NORMAL AND VIRUS TRANSFORMED 3T3 CELLS. 94
Cell surface glycosaminoglycans in normal and leukemic leukocytes. 94
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 94
Modulation of surface-associated urokinase in different cell lines: evidence for urokinase interiorization and degradation. 93
Plasminogen activator: morphological evidence of binding, internalization and delivery to lysosomes in 3T3 mouse fibroblasts. 92
Plasminogen activators and inhibitor type-1 in alveolar osteitis. 92
Glycosaminoglycan changes involved in polymorphonuclear leukocyte activation in vitro. 91
Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in endothelial progenitor cells. 91
I GLICOSAMINOGLICANI NELL'ADESIONE DEI LEUCOCITI POLIMORFONUCLEATI E DELLE PIASTRINE. 90
Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. 90
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 90
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. 89
PRODUCTION OF SECOND MESSENGERS FOLLOWING CHEMOTACTIC AND MITOGENIC UROKINASE-RECEPTOR INTERACTION IN HUMAN FIBROBLASTS AND MOUSE FIBROBLASTS TRANSFECTED WITH HUMAN UROKINASE RECEPTOR. 89
Cell surface glycosaminoglycans in normal and leukemic leukocytes. 87
Regulation of urokinase/urokinase receptor interaction by heparin-like glycosaminoglycans. 87
Cooperative effect of exogenous heparin-like compounds and secreted glucocorticoid-induced inhibitor on plasminogen activator in 3T3 cell cultures. 87
Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system. 86
Modulation of surface-associated urokinase: binding, interiorization, delivery to lysosomes, and degradation in human keratinocytes 86
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 86
Adhesion-dependent heparin production by platelets. 84
Endothelial sphingosine kinase/SPNS2 axis has a critical role in migration and vessel-like formation of human mesoangioblasts 84
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 83
Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis 83
Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts. 82
Modulation of growth of melanoma. 82
Proteases and extracellular environment. 81
Modulation of urokinase receptors on human synovial cells and osteoarthritic chondrocytes by diacetylrhein 81
Inhibition of spontaneous growth and induced differentiation of murine erythroleukaemia cells by paraquat and atrazine. 81
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. 81
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 81
Interaction of urokinase with specific receptors abolishes the time of commitment to terminal differentiation of murine erythroleukaemia (Friend) cells. 80
The plasminogen activation system in inflammation. 80
Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters 79
Modulation of surface-associated urokinase in different cell lines: evidence for urokinase interiorization and degradation. 78
Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells. 78
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 77
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein. 77
TGFb1 antagonistic peptides inhibit TGFb1-dependent angiogenesis 76
The Mr 17500 region of the A chain of urokinase is required for interaction with a specific receptor in A431 cells. 76
Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression 76
Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9. 75
Non-enzymatic activities of proteases: from scepticism to reality. 74
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a CTGF(CCN2)/TGF-beta-dependent mesechymal-to mesenchymal transition 74
One pot environmental friendly synthesis of gold nanoparticles using Punica Granatum Juice: A novel antioxidant agent for future dermatological and cosmetic applications 73
Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. 72
Involvement of chondroitin sulphate in preventing adhesive cellular interactions 72
Interaction of urokinase A-chain with the cellular receptor induces both urokinase autocriny and cell movement. 71
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells 70
Receptors for plasminogen activators, urokinase, in normal and Rous Sarcoma Virus-transformed mouse fibroblasts 68
Endothelial cells and normal breast epithelial cells empower invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. 67
Gold labeling of urokinase plasminogen activator. Characterization and specific binding in cultured mammalian cells. 67
bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity. 66
Antisense targeting of the urokinase receptor blocks urokinase-dependent proliferation, chemoinvasion, and chemotaxis of human synovial cells and chondrocytes in vitro. 65
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 65
PLASMINOGEN ACTIVATORS AND TIAPROFENIC ACID IN INFLAMMATION. A PRELIMINARY STUDY. 64
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice. 64
Anti-urokinase receptor antisense oligonucleotide (uPar-aODN) to prevent and cure long-term space exploration related retinal pathological angiogenesis 62
RALOXIFENE (RAL) MODULA IL PROFILO FIBRINOLITICO E RIDUCE CHEMIOINVASIONE E PROLIFERAZIONE NEI SINOVIOCITI (SI) REUMATOIDI (AR) BLOCCANDO L'INTERAZIONE U-PA/U-PAR E RIDUCENDO LA PRODUZIONE DI U-PA. REUMATISMO, 2004 VOL 56 N°3 (NUMERO SPECIALE 3) 62
null 62
Prep1 regulates angiogenesis through a PGC-1α-mediated mechanism 61
Antisense oligonucleotides against the urokinase receptor: a therapeutic strategy for the control of cell invasion in rheumatoid arthritis and cancer. 61
CHARACTERIZATION OF FIBRINOLYTIC PATTERN OF SYNOVIOCYTES FROM RHEUMATOID ARTHRITIS (RA). J RHEUMATOL , 28 (SUPPLEMENT 63) 60
Totale 10.447
Categoria #
all - tutte 35.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.860 0 0 50 191 235 272 204 304 201 142 215 46
2020/20211.780 133 151 107 186 76 214 97 146 154 273 104 139
2021/20221.022 34 93 41 53 41 55 30 75 60 49 225 266
2022/20232.810 272 458 128 239 235 482 352 210 307 12 61 54
2023/20241.016 34 118 145 46 60 151 39 278 14 62 38 31
2024/20251.204 236 684 284 0 0 0 0 0 0 0 0 0
Totale 12.309